Company Update: Gilead Sciences Inc (NASDAQ:GILD) – Technical Scrutiny on Biotechnology Stocks — Gilead Sciences, Sarepta Therapeutics, Dyax Corp., and Baxalta

[Accesswire] – NEW YORK, NY / ACCESSWIRE / January 21, 2016 / Park Lane Advisor has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), Sarepta Therapeutics Inc. (NASDAQ: SRPT), Dyax Corporation … Read more on this. Gilead Sciences Inc. (GILD) , with a current value of $129.40B, opened this morning at $90.38. During today’s session, GILD traded between $88.89 to $90.60 and has traded between $86.00 and $123.37 over the past year. Gilead (GILD) shares are currently priced at 7.42x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -4.23x earnings multiple for the same period. And for those looking to make a return holding the stock, the company pays shareholders $1.72 per share annually in dividends, yielding 1.91%. Consensus earnings for the current quarter by the 19 sell-side analysts covering the stock is an estimate of $2.99 per share, which would be $0.56 better than the year-ago quarter and a $0.16 sequential increase. What we find to be interesting is that the full-year EPS estimate of $12.21 is a $4.12 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $8.11 Billion. If reported, that would be a 10.94% increase over the year-ago quarter. Recently, Credit Suisse Initiated GILD at Outperform (Jan 20, 2016). Previously, BofA/Merrill upgraded GILD from Underperform to Neutral. The average price target for GILD shares by the analysts covering it is $123.24, which is 36.36% above where the stock opened. See more in (NASDAQ:GILD) Similar Articles: Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF) for the Treatment of Chronic Hepatitis B Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences Announces Fourth Quarter 2015 Dividend Company Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences to Release Third Quarter 2015 Financial Results on Tuesday, October 27, 2015